Trump Signs Executive Order to Limit Funding for Controversial Gain-of-Function Research
Titled 'Improving the Safety and Security of Biological Research,' the executive order directs the White House's Director of the Office of Science and Technology Policy to work with federal agencies to issue guidance that will end federal funding of all gain-of-function research in the U.S. and abroad. The order also directs agencies to track gain-of-function research in the U.S. that isn't federally funded and figure out how to stop it.
Gain-of-function research has trade-offs and has long been debated in the scientific community. The journal Nature published a study about how to create a mutant form of a bird flu in 2012 that was criticized at the time. And that feels especially relevant to those of us living through the current H5N1 outbreak that's jumped to cows and isn't yet transmissible from human to human.
But most of the debate around gain-of-function research has nothing to do with disclosing methods in scientific journals. The research is conducted to create a kind of 'pre-emptive strike' against potentially dangerous viruses to learn how they work, as Gizmodo explained in 2014. And while they have risks, they also have benefits. Being able to figure out how viruses could mutate allows for an early understanding of how to fight them with vaccines.
'Just about every mutation scientists can make, nature has already made,' Patrick Moore, virologist at the University of Pittsburgh, told Gizmodo in 2017. 'That's something we should be aware of, and that's why we have new viruses cropping up all the time.'
But the risks are very real. President Barack Obama halted funding for GOF research in 2014 after several security lapses involving lethal bugs, including anthrax at the CDC, smallpox at the FDA, and bird flu at the USDA. The NIH lifted a ban on gain-of-function research in late 2017 during President Trump's first term.
While there's real reasonable debate about the role of gain-of-function research and its safety, the press event at the White House on Monday included a lot of highly contested claims that are more the realm of conspiracy theorists than serious-minded health officials.
FDA commissioner Marty Makary, who was standing near Trump and Secretary Kennedy to talk with reporters as the president signed the EO, pushed a definitive narrative about the origins of covid-19 that is still very controversial.
'It's unbelievable to think the entire nightmare of covid was likely preventable, and you had good instincts early on, Mr. President, in suggesting it came from the Wuhan lab,' Makary told Trump. 'That is now the leading theory among scientists.'
The most recent studies on the lab leak theory, looking at genomic data, still suggest natural origins. Back in February, one study found that most virologists and other scientists with relevant expertise still don't think the lab leak theory is the best explanation for how covid-19 came into the world. But that doesn't fit with the tight narrative that Trump and his people want to believe. It's entirely possible that covid-19 was caused by a lab leak. We just don't have the solid data to support that idea and anyone using that as a rationale for banning gain-of-function research is probably trying to sell you on a worldview that relies less on science and more on ideology.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
French firm teams up with JetZero on hydrogen-powered flight
By Tim Hepher PARIS (Reuters) -A French technology startup unveiled plans on Wednesday to work with clean-aircraft venture JetZero to explore a potential hydrogen-powered variant of its futuristic all-wing design. The move by SHZ Advanced Technologies is likely to rekindle a debate over the potential for zero-emission flight, six months after Europe's Airbus put the brakes on plans to develop the world's first hydrogen-powered airliner. California-based JetZero aims to challenge the traditional duopoly of Airbus and Boeing by developing a so-called blended wing-body aircraft, which it claims will be able to cut fuel consumption - and therefore carbon emissions - in half. JetZero and SHZ now plan to work together under a NASA research programme to design systems capable of storing and distributing liquid hydrogen fuel, which could eliminate carbon emissions altogether and evolve into a variant of JetZero's Z4. Hydrogen is prized for its carbon-free emissions and high energy related to mass, which makes it lighter than normal fuel. However, it also takes up much more volume and must be cooled to -253 degrees Celsius, making storage a significant challenge. JetZero's blended wing-body design features a V-shaped fuselage that acts as a wing and reduces friction in the air, rather than the familiar wings and cylindrical fuselage. "Due to the wider fuselage, the airframe is far more compatible with (liquid hydrogen) fuel tanks without sacrificing passenger seating, as a 'tube and wing' airplane would," SHZ Advanced Technologies said on Wednesday. Airbus said in February it was slowing down efforts to produce a hydrogen-powered regional plane and dropped a target date of 2035, blaming a lack of supporting infrastructure. Boeing, by contrast, has been cool on the commercial viability of hydrogen flight altogether. The concept of a blended wing-body design has been around since the 1940s and led to the U.S. B-2 bomber, as well as the X-48 research project between Boeing and NASA some 18 years ago. JetZero is revisiting such designs as the aviation industry struggles to meet a target of net-zero emissions by 2050. Airbus has argued that combining such radical changes to the shape of a plane with an entirely new propulsion system would be too ambitious, and is focusing instead on hydrogen-based fuel cells inside a normal tubular aircraft configuration. But SHZ Advanced Technologies' co-founder Eric Schulz - a former senior executive at Rolls-Royce and Airbus - said JetZero would approach the task in two phases with the initial focus on a conventionally powered all-wing plane. Any hydrogen-based variant would come in a second step, he told Reuters. The French firm says it has developed hydrogen tanks that save space by avoiding the usual cylindrical shape needed for pressurised vessels and can fit more easily into the flowing contours of the Z4's fuselage. JetZero, whose backers include United Airlines, said in June it was on track to fly a full-scale prototype of the revolutionary 250-passenger airplane in 2027. Sign in to access your portfolio
Boston Globe
9 minutes ago
- Boston Globe
How hurricanes, fires, and floods put drugs and medical supplies at risk
Advertisement These threats are especially pressing as the Trump administration makes a push to ramp up US drug manufacturing, say the authors of the new research. As part of a broader effort to increase US pharmaceutical factories, President Donald Trump has threatened to impose tariffs on imported medicines, a move that could make the country more reliant on domestically produced supplies. Roughly 40% of finished medications and 80% of active pharmaceutical ingredient components come from abroad, according to US Food and Drug Administration estimates. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up 'Climate change-driven extreme weather events impose new threats to established vulnerabilities in the US drug supply,' the study's authors wrote. 'Those threats must be examined to be appropriately mitigated.' The analysis used FDA and Federal Emergency Management Agency databases to find drug production facilities in counties with major fire, hurricane, storm, tornado and flood events between 2019 and 2024. California, Florida and North Carolina were home to the largest numbers of facilities in counties with presidential disaster declarations. Advertisement Hurricanes were the most common of the climate-related disasters in areas with pharmaceutical facilities, according to the research. In 2017, Hurricane Maria hit Puerto Rico and disrupted Baxter's saline solution manufacturing facility there. Baxter is a major manufacturer of the sterile salt water widely used in hospitals to deliver medications and keep patients hydrated. The company didn't have backup facilities manufacturing smaller bags of the saline solution, which compounded pre-existing supply issues. Baxter has said it's learned from Maria and now has a more resilient supply chain, citing manufacturing investments and FDA clearance to produce saline outside of the US if needed. Even resilient supply chains are prone to climate shocks, though. Helene flooded Baxter's North Carolina facility, which made 60% of the IV fluid bags used in US hospitals for various functions, including to deliver medicine. Baxter reported earlier this year that the North Carolina plant was back at pre-hurricane production levels, and the FDA said this month that the shortages had resolved. Sarah Ryan, a spokesperson for pharmaceutical industry group PhRMA, says that the industry works with government regulators to avoid shortages. The new research did not determine how often such disasters result in shortages, saying that data wasn't readily available. ©2025 Bloomberg L.P.
Gizmodo
9 minutes ago
- Gizmodo
Rare Supernova Rips Open a Star, Revealing Its Hidden Anatomy
On September 6, 2021, Steve Schulze, a researcher at Northwestern University, was on the lookout for fresh supernovas when he came across a strange explosion that left behind an extremely exposed corpse. The dying star had a rather stressful death, stripping down to its stellar bone and exposing its inner layers. 'We quickly noticed that this supernova was unlike anything we had seen before,' Schulze told Gizmodo. As massive stars approach their death, they develop a structure of shells made up of different elements. Those shells are hard to observe, however, since the star's explosive death mixes the layers together. For the first time, astronomers have been able to see the distinct layers that make up a star through a recently discovered supernova, dubbed 2021yfj—and it is unlike anything they expected. The discovery, detailed in a new paper in the journal Nature, challenges existing models of stellar life cycles and the processes that lead to their explosive deaths. When stars are born, they're shiny balls of hydrogen. Due to the pressure and temperature at a star's core, the hydrogen fuses into helium, which then turns to carbon and so on until it produces iron at its core. 'This transforms the star into a layered structure,' Schulze said. A layer rich in oxygen, silicon, and sulfur is buried under many other materials and forms just months before the star explodes, making it impossible to observe directly—until now. The Zwicky Transient Facility in San Diego, California, first spotted supernova 2021yfj while monitoring the night skies every two to three days. Following initial observations, the researchers behind the discovery got to work in identifying the mysterious features of its spectrum and found that they were produced by silicon, sulfur, and argon. They also detected traces of helium in the supernova's spectrum. 'Any helium should have been consumed during earlier fusion stages,' Schulze said. 'So, detecting helium in the spectrum of SN 2021yfj is very puzzling.' The observations of a star stripped down to its oxygen- and silicon-rich layers are indicative of an extremely rare stripping process, which can occur due to strong stellar winds, eruptions, or interactions with a companion star, according to the researchers. 'This is the first time we observed the inner shells of a massive star, which is significant for testing and enhancing our models of stellar evolution,' Schulze said. 'Observations of stripped stars and supernovae are vital for improving and validating stellar evolution models.' 'SN 2021yfj reveals that our understanding of how massive stars evolve and end their lives is still incomplete,' he added.
